Srestha Finvest AGM to approve director appointments, related-party deals
- Srestha Finvest holds 41st AGM on September 30, 2026, via video conferencing
- Agenda includes appointing Dipesh Jaswantlal Shah and reappointing Sitaben S Patel
- Shareholders to approve related-party transactions with Rekha Bhandari, Prajal Bhandari, and Prajal Nutrifoods
- Proposed transaction limits total ₹75 crore over three years

*this image is generated using AI for illustrative purposes only.
Srestha Finvest has scheduled its 41st annual general meeting for September 30, 2026. The meeting will be held through video conferencing or other audio-visual means from its registered office in Chennai.
The board approved the notice on September 4, 2026. Key agenda items include the adoption of audited financial statements for FY26 and several special resolutions regarding board composition and related-party transactions.
Board Appointments
Shareholders will be asked to appoint Mr. Dipesh Jaswantlal Shah (DIN: 09511575) as a non-executive independent director. He was initially appointed as an additional director on July 3, 2026. The proposed term is five consecutive years, effective from July 3, 2026, until July 2, 2031.
The company will also seek approval for the reappointment of Mrs. Sitaben S Patel (DIN: 02470150) as a non-executive independent director. Her current term ends on October 27, 2026. The proposed second term spans five consecutive years, from October 28, 2026, to October 27, 2031.
| Director | Role | Term Start | Term End |
|---|---|---|---|
| Dipesh Jaswantlal Shah | Non-Executive Independent Director | July 3, 2026 | July 2, 2031 |
| Sitaben S Patel | Non-Executive Independent Director | October 28, 2026 | October 27, 2031 |
Related-Party Transactions
The AGM will consider ordinary resolutions approving material related-party transactions with three entities: Rekha Bhandari, Prajal Bhandari, and Prajal Nutrifoods Private Limited. These transactions are classified as material under Regulation 23 of the SEBI Listing Regulations.
The proposed limits for each counterparty over a three-year period (September 30, 2026, to September 30, 2029) are as follows:
- Rekha Bhandari: Lending up to ₹25 crore and borrowing up to ₹25 crore.
- Prajai Bhandari: Lending up to ₹25 crore and borrowing up to ₹25 crore.
- Prajai Nutrifoods Private Limited: Lending up to ₹25 crore, borrowing up to ₹25 crore, and acquisition of shares up to ₹25 crore.
The explanatory statement notes that these transactions are intended to augment financial resources, maintain liquidity, fund working capital, refinance existing borrowings, support business expansion, and meet general corporate purposes. The interest rates for lending and borrowing will align with prevailing bank lending rates.
The aggregate value of these proposed transactions represents approximately 269% of the company's annual standalone turnover for FY25-26, which was ₹743.50 lakh. The audit committee has reviewed and recommended these transactions to the board.
Meeting Details
The remote e-voting period begins on September 27, 2026, at 9:00 am and ends on September 29, 2026, at 5:00 pm. The record date for voting rights is September 23, 2026. The register of members and share transfer books will remain closed from September 24, 2026, to September 30, 2026.
The intimation was issued pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Historical Stock Returns for Srestha Finvest
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -4.00% | 0.0% | -11.11% | +26.32% | -40.00% | -84.81% |
How will the proposed related-party transactions, valued at 269% of annual turnover, impact Srestha Finvest's liquidity ratios and debt-to-equity structure over the next three years?
What specific strategic initiatives or business expansion plans is Srestha Finvest funding through the ₹25 crore share acquisition in Prajal Nutrifoods Private Limited?
Given the high volume of lending and borrowing with related parties, how does the company ensure these transactions remain at arm's length and comply with SEBI's strict guidelines on conflict of interest?
































